Ryan Dunlap is CFO at Galena Biopharma, Inc. (GALE). They have made 1 open-market trade across 1 company since 2016, most recently 2016-06-01.
CIK 0001554742
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GALE | 18,702 | $147K |
Shares reported on the most recent Form 4, priced at the 2016-06-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GALE | SELL | 2016-06-01 | 2016-06-07 | $2.18 | $553K | +9.9% | -74.5% | -80.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.